G6PD and malaria: In 2017, the standard G6PD test was registered in India and Thailand becoming the first quantitative G6PD point of care test available in a malaria endemic country. By 2018, the project led to one commercial product which received SRA in 2021; several other products in development, the approved test was being distributed in 30 countries by 2021 (84).